148 related articles for article (PubMed ID: 3488193)
21. Clinical and bacteriological evaluation of Branhamella catarrhalis in respiratory infections.
Saito A; Yamaguchi K; Shigeno Y; Kohno S; Shigeno H; Kusano N; Dotsu Y; Hara K
Drugs; 1986; 31 Suppl 3():87-92. PubMed ID: 3488201
[TBL] [Abstract][Full Text] [Related]
22. Determination of the antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis. Canadian Antimicrobial Study Group.
Blondeau JM; Suter M; Borsos S
J Antimicrob Chemother; 1999 Mar; 43 Suppl A():25-30. PubMed ID: 10225568
[TBL] [Abstract][Full Text] [Related]
23. Three methods for detecting synergy between sulphamethoxazole and trimethoprim against Branhamella catarrhalis.
Digiovanni C; Riley TV
J Antimicrob Chemother; 1987 Apr; 19(4):553-5. PubMed ID: 3583976
[No Abstract] [Full Text] [Related]
24. In-vitro activity of ciprofloxacin, ceftriaxone and five other antimicrobial agents against 95 strains of Brucella melitensis.
Bosch J; Liñares J; López de Goicoechea MJ; Ariza J; Cisnal MC; Martin R
J Antimicrob Chemother; 1986 Apr; 17(4):459-61. PubMed ID: 2940209
[TBL] [Abstract][Full Text] [Related]
25. The antimicrobial susceptibility of Moraxella catarrhalis isolated in England and Scotland in 1991.
Fung CP; Powell M; Seymour A; Yuan M; Williams JD
J Antimicrob Chemother; 1992 Jul; 30(1):47-55. PubMed ID: 1429336
[TBL] [Abstract][Full Text] [Related]
26. Clinical interpretation of beta-lactamase-producing strains of Branhamella catarrhalis in sputum Gram's stain and culture.
Robinson A; Johnson PC; Griffith SB
Am J Clin Pathol; 1987 Apr; 87(4):498-503. PubMed ID: 3548321
[TBL] [Abstract][Full Text] [Related]
27. In vitro activity of oral antimicrobial agents against clinical isolates of Pasteurella multocida.
Mortensen JE; Giger O; Rodgers GL
Diagn Microbiol Infect Dis; 1998 Feb; 30(2):99-102. PubMed ID: 9554176
[TBL] [Abstract][Full Text] [Related]
28. Branhamella catarrhalis respiratory infections in The Netherlands.
Maesen FP; Davies BI
Drugs; 1986; 31 Suppl 3():83-6. PubMed ID: 3732084
[TBL] [Abstract][Full Text] [Related]
29. In-vitro sensitivity of Bordetella pertussis.
Zackrisson G; Brorson JE; Krantz I; Trollfors B
J Antimicrob Chemother; 1983 May; 11(5):407-11. PubMed ID: 6307963
[TBL] [Abstract][Full Text] [Related]
30. In vitro susceptibility of upper respiratory tract pathogens to 13 oral antimicrobial agents.
Liebowitz LD; Saunders J; Koornhof HJ
S Afr Med J; 1987 Sep; 72(6):385-8. PubMed ID: 3660122
[TBL] [Abstract][Full Text] [Related]
31. [In vitro activity of cefuroxime against Moraxella (Branhamella) catarrhalis].
Laurans G; Gaudio F; Ducroix JP; Orfila J
Pathol Biol (Paris); 1991 May; 39(5):391-5. PubMed ID: 1909016
[TBL] [Abstract][Full Text] [Related]
32. Multicenter surveillance of antimicrobial resistance of Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 14 oral antibiotics.
Hsueh PR; Huang WK; Shyr JM; Lau YJ; Liu YC; Luh KT
J Formos Med Assoc; 2004 Sep; 103(9):664-70. PubMed ID: 15361938
[TBL] [Abstract][Full Text] [Related]
33. [The effect of cefaclor, doxycycline and other oral antibiotics on phagocytosis of polymorphonuclear granulocytes and PHA-induced stimulation of blood lymphocytes in man].
Hahn H; Kuhring D; Trautmann M; Diamantstein T
Arzneimittelforschung; 1985; 35(2):543-6. PubMed ID: 3873244
[TBL] [Abstract][Full Text] [Related]
34. In vitro activity of cefdinir against respiratory pathogens isolated in Sicily with reference to beta-lactamase production.
Blandino G; Aleo G; Caccamo F; Nicolosi VM; Siracusa V; Speciale A
J Chemother; 1996 Jun; 8(3):193-9. PubMed ID: 8808715
[TBL] [Abstract][Full Text] [Related]
35. Influence of cefaclor, phenethicillin, co-trimoxazole and doxycycline on colonization resistance in healthy volunteers.
Vollaard EJ; Clasener HA; van Griethuysen AJ; Janssen AJ; Sanders-Reijmers AH; Muller NF; Huige PJ
J Antimicrob Chemother; 1988 Nov; 22(5):747-58. PubMed ID: 3145269
[TBL] [Abstract][Full Text] [Related]
36. Sensitivity of enterococci to beta-lactam antibiotics, co-trimoxazole, nitrofurantoin, tetracycline and doxycycline.
Grimm H
Arzneimittelforschung; 1983; 33(3):419-23. PubMed ID: 6603227
[TBL] [Abstract][Full Text] [Related]
37. Susceptibility of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 17 oral antimicrobial agents based on pharmacodynamic parameters: 1998-2001 U S Surveillance Study.
Jacobs MR; Bajaksouzian S; Windau A; Good CE; Lin G; Pankuch GA; Appelbaum PC
Clin Lab Med; 2004 Jun; 24(2):503-30. PubMed ID: 15177851
[TBL] [Abstract][Full Text] [Related]
38. Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated from community-acquired respiratory tract infections in China: Results from the CARTIPS Antimicrobial Surveillance Program.
Zhang Y; Zhang F; Wang H; Zhao C; Wang Z; Cao B; Du Y; Feng X; Hu Y; Hu B; Ji P; Liu Z; Liu Y; Liao W; Lu J; Sun H; Wang Z; Xu X; Xu X; Yang Q; Yu Y; Zhang R; Zhuo C
J Glob Antimicrob Resist; 2016 Jun; 5():36-41. PubMed ID: 27436464
[TBL] [Abstract][Full Text] [Related]
39. Susceptibility of N Gonorrhoeae to penicillin, ampicillin, tetracycline, erythromycin, cotrimoxazole and supristol-an-in-vitro study.
Masshoor K; Bhujwala RA; Pandhi RK; Shriniwas ; Singh OP; Bhargava NC
Indian J Pathol Microbiol; 1980 Jul; 23(3):171-5. PubMed ID: 6780456
[No Abstract] [Full Text] [Related]
40. [Branhamella catarrhalis: incidence in pulmonary infections and determination of sensitivity to 5 antibiotics].
Texier-Maugein J; Escoubas J; Fouche J; Mormede M
Pathol Biol (Paris); 1988 May; 36(5):540-3. PubMed ID: 3136431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
